Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,856 | 48 | 43.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,428 | 5 | 37.0% |
| Travel and Lodging | $1,284 | 4 | 19.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Esperion Therapeutics, Inc. | $3,205 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $1,235 | 10 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $353.42 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $249.87 | 2 | $0 (2022) |
| ABBVIE INC. | $192.85 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $152.19 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $151.67 | 4 | $0 (2024) |
| AGEPHA Pharma FZ LLC | $128.99 | 1 | $0 (2024) |
| MDD US Operations, LLC | $113.72 | 1 | $0 (2021) |
| Incyte Corporation | $95.71 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,002 | 31 | Esperion Therapeutics, Inc. ($3,081) |
| 2023 | $496.21 | 7 | IDORSIA PHARMACEUTICALS US INC ($103.84) |
| 2022 | $512.85 | 5 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2021 | $1,557 | 14 | Amarin Pharma Inc. ($1,235) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $55.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 03/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Insomnia | ||||||
| 02/07/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $128.99 | General |
| Category: Cardiovascular Diseases | ||||||
| 01/24/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $91.23 | General |
| Category: Sleep Apnea testing | ||||||
| 11/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $79.26 | General |
| Category: Cardio-renal | ||||||
| 11/07/2023 | Astellas Pharma Global Development | Veozah (Drug) | Food and Beverage | In-kind items and services | $80.73 | General |
| Category: Biological | ||||||
| 11/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Obesity | ||||||
| 10/05/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $48.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $94.02 | General |
| Category: Interventional Urology | ||||||
| 09/13/2023 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $74.43 | General |
| Category: Men's Health | ||||||
| 05/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $103.84 | General |
| Category: INSOMNIA | ||||||
| 12/08/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $95.05 | General |
| Category: INSOMNIA | ||||||
| 11/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $72.93 | General |
| Category: Cardio-renal | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/20/2022 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $124.16 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/13/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $95.71 | General |
| Category: Dermatology | ||||||
| 11/11/2021 | MDD US Operations, LLC | APOKYN (Drug) | Food and Beverage | In-kind items and services | $113.72 | General |
| Category: NEUROLOGY | ||||||
| 09/25/2021 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/26/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $50.84 | General |
| 08/25/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Cardiovascular | ||||||
| 07/28/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $270.00 | General |
| Category: Cardiovascular | ||||||
| 07/13/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $270.00 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 251 | 433 | $60,099 | $26,430 |
| 2022 | 7 | 195 | 355 | $53,112 | $23,823 |
| 2021 | 6 | 194 | 337 | $45,071 | $21,436 |
| 2020 | 3 | 193 | 298 | $24,715 | $10,050 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 311 | $48,205 | $22,019 | 45.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,125 | 31.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 21 | 22 | $2,420 | $965.36 | 39.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 21 | 22 | $1,650 | $749.76 | 45.4% |
| 94681 | Test to measure exhaled air and carbon dioxide for evaluation of lung function | Office | 2023 | 21 | 22 | $1,760 | $625.68 | 35.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 21 | 22 | $1,364 | $584.32 | 42.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 22 | $1,100 | $361.02 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 283 | $43,865 | $19,948 | 45.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,100 | $2,177 | 42.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 11 | 11 | $1,210 | $495.43 | 40.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 11 | 11 | $825.00 | $393.61 | 47.7% |
| 94681 | Test to measure exhaled air and carbon dioxide for evaluation of lung function | Office | 2022 | 11 | 11 | $880.00 | $327.15 | 37.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 11 | 11 | $682.00 | $297.94 | 43.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 11 | 11 | $550.00 | $183.68 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 247 | $38,285 | $18,640 | 48.7% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 18 | 18 | $1,980 | $772.14 | 39.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 18 | 18 | $1,350 | $658.16 | 48.8% |
| 94681 | Collection and analysis of exhaled air and carbon dioxide for evaluation of lung function | Office | 2021 | 18 | 18 | $1,440 | $537.88 | 37.4% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 18 | 18 | $1,116 | $494.64 | 44.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 18 | 18 | $900.00 | $333.36 | 37.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 111 | $17,205 | $6,212 | 36.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 48 | 57 | $6,860 | $3,455 | 50.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 76 | 130 | $650.00 | $383.82 | 59.0% |
About Deirdre Detraz, ANPC
Deirdre Detraz, ANPC is a Adult Health healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396761060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deirdre Detraz, ANPC has received a total of $6,568 in payments from pharmaceutical and medical device companies, with $4,002 received in 2024. These payments were reported across 57 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,856).
As a Medicare-enrolled provider, Detraz has provided services to 833 Medicare beneficiaries, totaling 1,423 services with total Medicare billing of $81,739. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Lafayette, LA
- Active Since 07/14/2006
- Last Updated 11/08/2024
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396761060
Products in Payments
- NEXLIZET (Drug) $3,019
- Vascepa (Drug) $1,235
- QUVIVIQ (Drug) $353.42
- FARXIGA (Drug) $249.87
- NEXLETOL (Drug) $186.88
- Kerendia (Drug) $152.19
- LODOCO (Drug) $128.99
- QULIPTA (Drug) $123.65
- APOKYN (Drug) $113.72
- LEQVIO (Drug) $104.18
- OPZELURA (Drug) $95.71
- VOQUEZNA (Drug) $95.05
- UROLIFT (Device) $94.02
- WatchPATONE (Device) $91.23
- Veozah (Drug) $80.73
- Korlym (Drug) $75.26
- Titan (Device) $74.43
- VRAYLAR (Drug) $69.20
- LINQ II (Device) $32.81
- ENTRESTO (Drug) $25.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Lafayette
Mr. Matt Landry, N.p, N.P
Adult Health — Payments: $46,500
Mrs. Samantha Williams, Np-C, NP-C
Adult Health — Payments: $5,152
Laurie Lee, Anp-Bc, ANP-BC
Adult Health — Payments: $4,406
Rebecca Cutchin, Anp, ANP
Adult Health — Payments: $3,049
Mrs. Heather Daigle, Aprn, Anp-C, APRN, ANP-C
Adult Health — Payments: $2,842
Kristen Lasseigne, Msn, Acnpc-Ag, MSN, ACNPC-AG
Adult Health — Payments: $2,318